Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
-
Information for professionals for TOBI
-
Änderungen
-
21.03.2019
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
2 Änderungen an Fachinfo TOBI
-
Novartis
Pharma
Schweiz AG, Risch; Domizil: 6343 Rotkreuz.
+
Mylan
Pharma
GmbH, 6312 Steinhausen
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
